Who owns the DENKI trademark?

The DENKI trademark is owned by PHARMALEADS.

What is the serial number for DENKI?

The USPTO serial number for DENKI is 79252701.

What is the registration number for DENKI?

DENKI is registered under USPTO registration number 6004513.

DEN

USPTO Trademark Record

REGISTERED

DENKI

Q: What class is the DENKI trademark registered in?

The DENKI trademark is registered in Class 001 (Chemicals for industrial, scientific & agricultural use), Class 042 (Scientific, technology & SaaS services).

SN 79252701·Reg 6004513·Filed Jan 15, 2019

Owner PHARMALEADS

Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fire extinguishing and fire prevention compositions; tempering and soldering preparations; substances for tanning animal skins and hides; adhesives for use in industry; compost, manures, fertilizers; biological preparations for use in industry and science.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

DENKI (Serial No. 79252701), Registration No. 6004513, is a registered US trademark filed on Jan 15, 2019 by PHARMALEADS. This trademark covers Class 001 (Chemicals for industrial, scientific & agricultural use), Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: March 11, 2030

Mark Intelligence

DENKI (Reg. #6004513) is a registered US trademark that has been protecting its owner, PHARMALEADS, since 2019. The mark covers Class 001 (Chemicals for industrial, scientific & agricultural use) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocesse.... The mark faced 3 opposition proceedings during prosecution.

FILED

Jan 15, 2019

SERIAL

79252701

REG#

6004513

REGISTERED

Mar 10, 2020

Owner

Applicant

PHARMALEADS

Entity

Not Provided

Address

Immeuble Paris Biopark, 11 Rue Watt, F-75013 PARIS

Country

Attorney

NameDianne M. Smith-Misemer

Law firm

Dianne M. Smith-Misemer HOVEY WILLIAMS LLP

Docket

52987/5183

Address

10801 Mastin Boulevard, Suite 1000, Overland Park, KS 66210, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 15, 2019

Serial Number79252701

Registration No.6004513

Registration DateMar 10, 2020

Status DateMar 10, 2020

Published for OppositionDec 24, 2019

Next RenewalMarch 11, 2030

Mark TypeStandard characters

Attorney Docket52987/5183

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 001Chemicals for industrial, scientific & agricultural use

US codes: 001, 005, 006, 010, 026, 046

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

45 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Mar 10, 2025

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

Jul 21, 2021

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

CORRECTION TRANSACTION RECEIVED FROM IB

Jul 10, 2021

CORRECTION TRANSACTION RECEIVED FROM IB

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

Jan 05, 2021

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Jan 04, 2021

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 07, 2020

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jul 20, 2020

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jul 20, 2020

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 10, 2020

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

LIMITATION FROM THE IB EXAMINED AND ENTERED

Apr 24, 2020

LIMITATION FROM THE IB EXAMINED AND ENTERED

ASSIGNED TO PARALEGAL

Apr 23, 2020

ASSIGNED TO PARALEGAL

CORRECTION UNDER SECTION 7 - PROCESSED

Apr 23, 2020

CORRECTION UNDER SECTION 7 - PROCESSED

LIMITATION OF GOODS RECEIVED FROM IB

Mar 20, 2020

LIMITATION OF GOODS RECEIVED FROM IB

REGISTERED-PRINCIPAL REGISTER

Mar 10, 2020

REGISTERED-PRINCIPAL REGISTER

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

Feb 04, 2020

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

Jan 22, 2020

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

NOTIFICATION PROCESSED BY IB

Jan 03, 2020

NOTIFICATION PROCESSED BY IB

PUBLISHED FOR OPPOSITION

Dec 24, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 24, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Dec 18, 2019

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 18, 2019

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 04, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LIMITATION OF GOODS RECEIVED FROM IB

Nov 29, 2019

LIMITATION OF GOODS RECEIVED FROM IB

Nov 22, 2019

LIMITATION OF GOODS RECEIVED FROM IB

ASSIGNED TO LIE

Nov 15, 2019

ASSIGNED TO LIE

EXAMINERS AMENDMENT -WRITTEN

Nov 13, 2019

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Nov 13, 2019

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 13, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Nov 13, 2019

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 13, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 25, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 24, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 24, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

May 18, 2019

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

May 02, 2019

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 02, 2019

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 10, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Apr 09, 2019

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

Apr 08, 2019

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 28, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

ASSIGNED TO EXAMINER

Mar 27, 2019

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Mar 27, 2019

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

Mar 05, 2019

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 27, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 21, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

DENKI

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by PHARMALEADS

Other Marks by Dianne M. Smith-Misemer

Resources

Company